ovarian cancer still presents significant challenges in diagnosis and treatment. Ovarian cancer is known for its rapid progression and ability to metastasize to distant organs, which greatly reduces the chances of successful treatment. Early detection and timely intervention are crucial for improving survival rates.Currently, there are several advancements in the field of ovarian cancer therapeutics. Targeted therapy, which focuses on blocking specific molecular pathways involved in tumor growth and progression, has shown promising results in some cases. Immunotherapy, which utilizes the body's immune system to attack cancer cells, is also being explored as a new approach. However, these treatments are not yet widely available and are often accompanied by side effects. Furthermore, the complexity of ovarian cancer, including its heterogeneous nature and ability to evade immune responses, makes it difficult to develop more effective and universally applicable treatments.Continued research is needed to improve the understanding of ovarian cancer's mechanisms and to develop more innovative and effective treatments. This includes further studying the genetic and epigenetic factors associated with the disease, as well as exploring new therapeutic strategies such as precision medicine. Innovative clinical trials and partnerships between researchers and medical institutions are essential for bringing new treatments to patients as soon as possible. Additionally, improving diagnostic techniques and increasing awareness among women about ovarian cancer risk factors and symptoms can also contribute to earlier detection and better treatment outcomes.In summary, ovarian cancer remains a difficult disease to combat, but there is progress being made in the field of oncology. By continuing to invest in research and collaboration, we can hope to improve the prognosis and quality of life for patients with this disease.